Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08992 | 31913326 | Sci Rep | Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women. | 2020 | Details |
| A08994 | 31911565 | Anatol J Cardiol | Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography. | 2020 | Details |
| A08996 | 31910634 | Arch Iran Med | Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review. | 2020 | Details |
| A08997 | 31910319 | Liver Int | Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality. | 2020 | Details |
| A08998 | 31909773 | Food Funct | Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice. | 2020 | Details |
| A08999 | 31909357 | Hepatol Commun | A Microphysiological System for Studying Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09000 | 31909356 | Hepatol Commun | Circulating MicroRNA-122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD. | 2019 | Details |
| A09001 | 31908512 | Diabetes Metab Syndr Obes | The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases. | 2019 | Details |
| A09002 | 31908001 | FASEB J | An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes. | 2019 | Details |
| A09003 | 31907981 | J Gastroenterol Hepatol | Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one. | 2020 | Details |
| A09004 | 31907854 | Drug Saf | Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring. | 2020 | Details |
| A09005 | 31907542 | Inflamm Bowel Dis | Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease. | 2020 | Details |
| A09006 | 31907123 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice]. | 2019 | Details |
| A09007 | 31906832 | Stroke | Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage. | 2020 | Details |
| A09008 | 31906711 | Physiol Int | A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease. | 2019 | Details |
| A09009 | 31905727 | Nutrients | Intestinal Fructose and Glucose Metabolism in Health and Disease. | 2019 | Details |
| A09010 | 31905444 | Ann Pediatr Endocrinol Metab | Application of body composition zones in boys with nonalcoholic fatty liver disease. | 2019 | Details |
| A09011 | 31905026 | Am J Physiol Gastrointest Liver Physiol | Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. | 2020 | Details |
| A09012 | 31905025 | Am J Physiol Gastrointest Liver Physiol | Investigating fibrosis and inflammation in an ex vivo NASH murine model. | 2020 | Details |
| A09014 | 31904420 | Biochim Biophys Acta Mol Cell Biol Lipids | Carotenoids and fatty liver disease: Current knowledge and research gaps. | 2020 | Details |
| A09015 | 31903720 | Liver Int | Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation. | 2020 | Details |
| A09016 | 31903714 | Liver Int | Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? | 2020 | Details |
| A09019 | 31902937 | Biol Pharm Bull | Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model. | 2020 | Details |
| A09020 | 31902357 | Mini Rev Med Chem | Phytoestrogens and NAFLD: Possible Mechanisms of Action. | 2020 | Details |
| A09021 | 31901728 | Redox Biol | Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. | 2019 | Details |
| A09022 | 31901607 | Med Hypotheses | Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease? | 2019 | Details |
| A09025 | 31900291 | Gut | Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. | 2020 | Details |
| A09026 | 31899984 | Expert Opin Investig Drugs | Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A09028 | 31899128 | Ann Hepatol | Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. | 2019 | Details |
| A09030 | 31899023 | Rev Mal Respir | [Prevalence and risk factors for fatty liver in Tunisian adults with obstructive sleep apnea]. | 2019 | Details |
| A09031 | 31898413 | Am J Transplant | OPTN/SRTR 2018 Annual Data Report: Liver. | 2020 | Details |
| A09032 | 31898379 | NMR Biomed | Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. | 2020 | Details |
| A09033 | 31897838 | Eur J Pediatr | Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years. | 2020 | Details |
| A09034 | 31897769 | Acta Diabetol | Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. | 2020 | Details |
| A09035 | 31896166 | J Gastroenterol Hepatol | Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases. | 2020 | Details |
| A09036 | 31895886 | Eur J Gastroenterol Hepatol | Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis. | 2020 | Details |
| A09037 | 31894585 | J Food Biochem | Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized rats. | 2020 | Details |
| A09038 | 31894315 | Int J Mol Med | miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1. | 2019 | Details |
| A09039 | 31894013 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | [Review of macrophage heterogeneity and progression of nonalcoholic fatty liver disease]. | 2019 | Details |
| A09040 | 31893310 | Cell Mol Life Sci | Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism. | 2019 | Details |
| A09041 | 31892608 | Anticancer Res | Vitamin D in Preclinical Models of Fatty Liver Disease. | 2020 | Details |
| A09042 | 31892367 | Clin Epigenetics | Newborn and childhood differential DNA methylation and liver fat in school-age children. | 2019 | Details |
| A09043 | 31891747 | J Steroid Biochem Mol Biol | Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in korean older adults. | 2019 | Details |
| A09044 | 31891606 | PLoS One | Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A09045 | 31890671 | J Diabetes Metab Disord | The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. | 2019 | Details |
| A09046 | 31889755 | J Clin Exp Hepatol | Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09047 | 31889754 | J Clin Exp Hepatol | Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09048 | 31889753 | J Clin Exp Hepatol | Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults? | 2019 | Details |
| A09049 | 31889539 | Transplant Proc | Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2019 | Details |
| A09050 | 31889412 | IUBMB Life | Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway. | 2019 | Details |
| A09051 | 31889396 | Liver Int | Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease. | 2020 | Details |
| A09053 | 31888241 | Nutrients | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial. | 2019 | Details |
| A09054 | 31888190 | Nutrients | Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. | 2019 | Details |
| A09055 | 31888132 | Nutrients | Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2019 | Details |
| A09056 | 31888083 | Int J Mol Sci | Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules. | 2019 | Details |
| A09057 | 34350368 | Cardiol Plus | Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy. | 2020 | Details |
| A09058 | 33837698 | Curr Top Membr | Membrane modulatory effects of omega-3 fatty acids: Analysis of molecular level interactions. | 2020 | Details |
| A09059 | 33762794 | Toxicol Environ Chem | Perfluorobutanesulfonic Acid (PFBS) Induces Fat Accumulation in HepG2 Human Hepatoma. | 2020 | Details |
| A09060 | 33740854 | Vnitr Lek | The role of metabolic syndrome in the induction of chronic pancreatitis after a first attack of acute pancreatitis - multicenter trial. | 2020 | Details |
| A09061 | 31887811 | Gut Liver | Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. | 2020 | Details |
| A09062 | 31887451 | Clin Gastroenterol Hepatol | High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09063 | 31887443 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study. | 2019 | Details |
| A09065 | 31887369 | J Hepatol | A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. | 2019 | Details |
| A09066 | 31885789 | Oxid Med Cell Longev | Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. | 2019 | Details |
| A09067 | 31885746 | Dis Markers | Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study. | 2019 | Details |
| A09068 | 31885733 | Dis Markers | Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09069 | 31885541 | Gastroenterol Res Pract | Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09070 | 31885103 | Fundam Clin Pharmacol | Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats. | 2020 | Details |
| A09071 | 31885010 | Iran J Immunol | Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09072 | 31884405 | Phytomedicine | Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2/HO-1 antioxidant signaling pathway. | 2019 | Details |
| A09073 | 31883528 | Lipids Health Dis | Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet. | 2019 | Details |
| A09074 | 31883514 | BMC Gastroenterol | Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH. | 2019 | Details |
| A09075 | 31883410 | Liver Int | Hepatitis B virus activity is not associated with degree of liver steatosis in patients with hepatitis B-related chronic liver disease. | 2020 | Details |
| A09076 | 31883408 | Liver Int | Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease. | 2020 | Details |
| A09077 | 31883216 | Hepatol Res | Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction. | 2020 | Details |
| A09078 | 31882889 | Sci Rep | Hepatic Mitochondrial Oxidative Metabolism and Lipogenesis Synergistically Adapt to Mediate Healthy Embryonic-to-Neonatal Transition in Chicken. | 2019 | Details |
| A09079 | 31882668 | Sci Rep | Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. | 2019 | Details |
| A09080 | 31882566 | Diabetes | The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH. | 2019 | Details |
| A09081 | 31882442 | Pharmacol Rev | Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease. | 2020 | Details |
| A09082 | 31882273 | J Diabetes Complications | Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. | 2019 | Details |
| A09083 | 31881781 | Int J Mol Sci | FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09084 | 31881392 | Contemp Clin Trials | Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. | 2019 | Details |
| A09085 | 31881361 | Cell Mol Gastroenterol Hepatol | Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. | 2019 | Details |
| A09086 | 31881272 | Pharmacol Res | The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease. | 2019 | Details |
| A09087 | 31881201 | Exp Mol Pathol | Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver. | 2019 | Details |
| A09088 | 31881192 | Biochem Pharmacol | Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance. | 2019 | Details |
| A09090 | 31880680 | J Pediatr Gastroenterol Nutr | Early Obesity: Risk Factor for Fatty Liver Disease. | 2020 | Details |
| A09091 | 31880257 | Curr Protein Pept Sci | Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients. | 2020 | Details |
| A09092 | 31880161 | Rev Esp Enferm Dig | Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome. | 2020 | Details |
| A09093 | 31880002 | J Clin Lab Anal | Middle- and high-molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease. | 2019 | Details |
| A09094 | 31879571 | PeerJ | Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH. | 2019 | Details |
| A09095 | 31877961 | Nutrients | Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model. | 2019 | Details |
| A09096 | 31877771 | Cells | Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. | 2019 | Details |
| A09097 | 31877680 | Int J Mol Sci | Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09098 | 31877412 | Mol Ther Nucleic Acids | Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile. | 2019 | Details |
| A09099 | 31877356 | Free Radic Biol Med | The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress. | 2019 | Details |
| A09101 | 31876010 | Microcirculation | Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease. | 2020 | Details |
| A09102 | 31875010 | Sci Rep | The assessment of liver fibrosis in children with obesity on two methods: transient and two dimensional shear wave elastography. | 2019 | Details |
| A09103 | 31874999 | Sci Rep | FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis. | 2019 | Details |
| A09104 | 31873887 | Environ Sci Pollut Res Int | Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004. | 2019 | Details |